{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:27:08Z","timestamp":1771327628045,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.imbio.2014.12.006","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T21:47:09Z","timestamp":1420667229000},"page":"564-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events"],"prefix":"10.1016","volume":"220","author":[{"given":"A.C.","family":"Campi-Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.S.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Silveira-Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Vitelli-Avelar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sathler-Avelar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"B\u00e9la","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.F.","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.C.C.","family":"Schachnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Correa-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Eloi-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.A.","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2014.12.006_bib0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/jaut.2001.0523","article-title":"Chronic Chagas\u2019 disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection","volume":"17","author":"Abel","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.imbio.2014.12.006_bib0010","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/315743","article-title":"Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14\u201330 years ago","volume":"182","author":"Bahia-Oliveira","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2014.12.006_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000176409","article-title":"Noninvasive predictors of mortality for patients with Chagas\u2019 heart disease: a multivariate stepwise logistic regression study","volume":"84","author":"Bestetti","year":"1994","journal-title":"Cardiology"},{"key":"10.1016\/j.imbio.2014.12.006_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1051\/parasite\/2014012","article-title":"Chagas disease in the 21st Century: a public health success or an emerging threat?","volume":"21","author":"Bonney","year":"2014","journal-title":"Parasite"},{"key":"10.1016\/j.imbio.2014.12.006_bib0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm1744","article-title":"Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease","volume":"14","author":"Bustamante","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2014.12.006_bib0030","first-page":"43","article-title":"Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media","volume":"6","author":"Camargo","year":"1964","journal-title":"Rev. Inst. Med. Trop. S\u00e3o Paulo"},{"key":"10.1016\/j.imbio.2014.12.006_bib0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/596061","article-title":"Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy","volume":"199","author":"Costa","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2014.12.006_bib0040","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(96)04128-1","article-title":"Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection","volume":"348","author":"de Andrade","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2014.12.006_bib0045","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.imbio.2012.04.008","article-title":"Foxp3(+)CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity","volume":"217","author":"de Ara\u00fajo","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2014.12.006_bib0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1046\/j.1365-3024.1996.d01-29.x","article-title":"Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy","volume":"18","author":"Dutra","year":"1996","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.imbio.2014.12.006_bib0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0167-5273(91)90095-7","article-title":"Prognostic indicators of chronic chagasic cardiopathy","volume":"30","author":"Espinosa","year":"1991","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.imbio.2014.12.006_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0037-86822007000100001","article-title":"Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution","volume":"40","author":"Fabbro","year":"2007","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.imbio.2014.12.006_bib0065","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1590\/S1516-31801995000200020","article-title":"Etiologic treatment of acute and chronic Chagas disease","volume":"113","author":"Fragata-Filho","year":"1995","journal-title":"S\u00e3o Paulo Med. J."},{"key":"10.1016\/j.imbio.2014.12.006_bib0070","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental Chagas\u2019 disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.imbio.2014.12.006_bib0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/IAI.71.3.1185-1193.2003","article-title":"Evidence that development of severe cardiomyopathy in human Chagas\u2019 disease is due to a Th1-specific immune response","volume":"71","author":"Gomes","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2014.12.006_bib0080","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.imbio.2012.01.014","article-title":"Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease","volume":"217","author":"Gomes","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.imbio.2014.12.006_bib0085","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1086\/648072","article-title":"Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy","volume":"49","author":"Laucella","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2014.12.006_bib0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/381682","article-title":"Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease","volume":"189","author":"Laucella","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2014.12.006_bib0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/jir439","article-title":"Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody","volume":"204","author":"Luiza-Silva","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"Suppl 3","key":"10.1016\/j.imbio.2014.12.006_bib0500","first-page":"7","article-title":"Brazilian Consensus on Chagas disease, Secretaria de Vigil\u00e2ncia em Sa\u00fade","volume":"38","author":"Minist\u00e9rio da Sa\u00fade","year":"2005","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.imbio.2014.12.006_bib0100","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","article-title":"Pathogenesis of chronic Chagas heart disease","volume":"115","author":"Marin-Neto","year":"2007","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.imbio.2014.12.006_bib0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1590\/S0074-02762009000900042","article-title":"The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease","volume":"104","author":"Marin-Neto","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.imbio.2014.12.006_bib0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2008.04.001","article-title":"Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas\u2019 cardiomyopathy: the benznidazole evaluation for interrupting trypanosomiasis (BENEFIT)","volume":"156","author":"Marin-Neto","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.imbio.2014.12.006_bib0115","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1128\/AAC.42.10.2549","article-title":"Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi","volume":"42","author":"Michailowsky","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.imbio.2014.12.006_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1590\/S0074-02762009000900005","article-title":"Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy","volume":"104","author":"Moncayo","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.imbio.2014.12.006_bib0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s004360000357","article-title":"Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats","volume":"87","author":"Piaggio","year":"2001","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.imbio.2014.12.006_bib0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0037-86821999000500002","article-title":"Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases","volume":"32","author":"Rassi","year":"1999","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.imbio.2014.12.006_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2249.1999.01053.x","article-title":"Benznidazole, a drug employed in the treatment of Chagas\u2019 disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages","volume":"118","author":"Revelli","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2014.12.006_bib0140","first-page":"CD004102","article-title":"Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)","volume":"19","author":"Reyes","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.imbio.2014.12.006_bib0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2334-12-123","article-title":"Blood leukocytes from benznidazole-treated indeterminate Chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens","volume":"12","author":"Sathler-Avelar","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.imbio.2014.12.006_bib0150","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-3083.2006.01843.x","article-title":"Benznidazole treatment during early-indeterminate Chagas\u2019 disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile","volume":"64","author":"Sathler-Avelar","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2014.12.006_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.micinf.2007.10.009","article-title":"Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern","volume":"10","author":"Sathler-Avelar","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.imbio.2014.12.006_bib0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jim.2009.01.010","article-title":"Intracellular nitric oxide assessment in whole blood leukocytes by flow cytometry: optimization and applicability to monitor patients with chronic graft nephropathy","volume":"343","author":"Schachnik","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imbio.2014.12.006_bib0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.pt.2006.09.011","article-title":"The future of Chagas disease control","volume":"22","author":"Schofield","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.imbio.2014.12.006_bib0175","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.imbio.2014.12.006_bib0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/01.qco.0000247592.21295.a5","article-title":"Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina","volume":"19","author":"Sosa-Estani","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.imbio.2014.12.006_bib0185","doi-asserted-by":"crossref","first-page":"e87082","DOI":"10.1371\/journal.pone.0087082","article-title":"Plasma cytokine expression is associated with cardiac morbidity in Chagas disease","volume":"9","author":"Sousa","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2014.12.006_bib0190","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/IAI.01931-06","article-title":"Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas\u2019 disease","volume":"75","author":"Souza","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2014.12.006_bib0195","first-page":"35","article-title":"Interpretation of the correlation coefficient: a basic review","volume":"1","author":"Taylor","year":"1990","journal-title":"JDMS"},{"key":"10.1016\/j.imbio.2014.12.006_bib0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cyto.990170404","article-title":"Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes","volume":"17","author":"Van Amersfoort","year":"1994","journal-title":"Cytometry"},{"key":"10.1016\/j.imbio.2014.12.006_bib0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-8703(94)90521-5","article-title":"Treatment of chronic Chagas\u2019 disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up","volume":"127","author":"Viotti","year":"1994","journal-title":"Am. Heart J."},{"key":"10.1016\/j.imbio.2014.12.006_bib0210","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.imbio.2014.12.006_bib0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/hrt.2003.018960","article-title":"Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure","volume":"90","author":"Viotti","year":"2004","journal-title":"Heart"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298514002757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298514002757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:38:03Z","timestamp":1759250283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298514002757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0171298514002757"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2014.12.006","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}